Alfonso Utrilla-Gonzalez

Granada, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.

Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.

Journal: The pharmacogenomics journal

Published: February 15, 2019

Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium.

Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium.

Journal: Scientific reports

Published: January 24, 2019

Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.

Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.

Journal: The pharmacogenomics journal

Published: November 29, 2017

Influence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis.

Influence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis.

Journal: The pharmacogenomics journal

Published: June 29, 2016

Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.

Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.

Journal: Pharmacological research

Published: March 25, 2016

Two-year efficacy of tocilizumab in patients with active rheumatoid arthritis in clinical practice.

Two-year efficacy of tocilizumab in patients with active rheumatoid arthritis in clinical practice.

Journal: Reumatologia clinica

Published: October 09, 2015

Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response: a two-stage case-control study.

Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response: a two-stage case-control study.

Journal: Pharmacogenetics and genomics

Published: June 26, 2015

Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter study.

Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter study.

Journal: Pharmacogenetics and genomics

Published: April 09, 2015

Gender-specific effects of genetic variants within Th1 and Th17 cell-mediated immune response genes on the risk of developing rheumatoid arthritis.

Gender-specific effects of genetic variants within Th1 and Th17 cell-mediated immune response genes on the risk of developing rheumatoid arthritis.

Journal: PloS one

Published: January 23, 2013

Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.

Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.

Journal: Omics : a journal of integrative biology

Published: October 26, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026